This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

NCT03207750 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1280

Enrollment

INDUSTRY

Sponsor class

Conditions

Rotavirus Infection
Rotavirus Vaccines

Interventions

BIOLOGICAL: Rotarix
BIOLOGICAL: Pediarix
BIOLOGICAL: Hiberix
BIOLOGICAL: Prevenar 13

Sponsor

GlaxoSmithKline